Skip to main content
OpenTrials
Completed

NCT Number: NCT05591950

Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)

Intensive care unit acquired weakness (ICUAW) is a common issue in critically ill patients. Early mobilization can reduce the occurrence of ICUAW. This requires a standardized procedure based on validated scales. One such scale is Carol Hodgson's ICU Mobility Scale (IMS).

The subject of the study is the translation of the IMS into German and the validation of its reliability and predictive power with regard to various clinical outcomes. Furthermore we want to investigate the communication about the mobilisation status of ICU-patients between the different medical disciplines that are involved in patient care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Muscle Weakness Critical Illness Disease Attributes Early Mobilization Mechanical Ventilation Complication Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Charité - Univiversitätsmedizin Berlin

Berlin, State of Berlin, 10117, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Critically ill adults (age: ≥ 18 years)
  • Expected length of stay in ICU > 24h
  • Ventilation support

Exclusion criteria

  • Patients transferred from other ICUs
  • Patients with pre-existing functional limitations
  • Patients with functional limitations due to the admission diagnosis (e.g. stroke. with hemiparesis)

Treatment and study plan

Primary outcomes

  1. Predictive validity of the IMS

    Time frame: approximate 28 days (till ICU discharge)

    Predictive validity of the IMS-score performed in the first 24 hours after admission to the ICU for the length of stay in the ICU

Secondary outcomes

  1. ICU mortality

    Time frame: approximate 28 days (till ICU discharge)

    Mortality during ICU stay

  2. Duration of mechanical ventilation

    Time frame: approximate 28 days (till ICU discharge)

    Duration of invasive mechanical ventilator dependency

  3. Discharge location

    Time frame: approximate at 28 days (at hospital discharge)

    If the patient was discharged home or to another facility at hospital discharge

  4. MRC Score

    Time frame: approximate 28 days (till ICU discharge)

    Muscle strength at ICU discharge measured using the Medical Research Council score

  5. Muscle strength

    Time frame: approximate 28 days (till ICU discharge)

    Muscle strength at ICU discharge measured using hand grip strength

  6. 90-day mortality

    Time frame: at 90 days

    Mortality at 90 days

  7. 90-day function

    Time frame: at 90 days

    Physical function of the patient at 90 days

  8. IMS during the ICU stay

    Time frame: approximate 28 days (till ICU discharge)

    achieved mobilization level during the ICU stay using the ICU Mobility Scale (IMS)

  9. ICU-LOS

    Time frame: approximate 28 days (till ICU discharge)

    Length of stay in the ICU

  10. Hospital LOS

    Time frame: approximate 28 days (till discharge)

    Length of stay in the hospital

  11. in-hospital mortality

    Time frame: approximate 28 days (till discharge)

    Mortality during the Hospital stay

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Official study title

Übersetzung Und Validierung Einer Deutschen Version Der Intensive Care Unit Mobility Scale (IMS) Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)

Acronym: TAVIMS

Important dates

Study start
2023
Primary completion
2024
Study completion
2025
First posted
Oct 24, 2022
Registry last updated
Apr 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.